AT521638T
Antibodies directed to angiopoietin-2 and uses thereof
Abstract
This record has no abstract on file.
Term
Term ended
Expired 19 December 2025, 0.8 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
52 members in 27 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 63835404 | United States of America | P | |
| 71128905 | United States of America | P | |
| 2005045657 | United States of America | W |
Members52
| Document | Office | Kind | |
|---|---|---|---|
| AU2005319382A1 | Australia | A1 | |
| CA2595610A1 | Canada | A1 | |
| CA2799802A1 | Canada | A1 | |
| WO2006068953A2 | World Intellectual Property Organization (WIPO) | A2 | |
| UY29288A1 | Uruguay | A1 | |
| TW200634027A | Taiwan Province of China | A | |
| US2006246071A1 | United States of America | A1 | |
| AR052065A1 | Argentina | A1 | |
| MX2007007484A | Mexico | A | |
| WO2006068953A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20073192L | Norway | L | |
| EP1838733A2 | European Patent Office (EPO) | A2 | |
| KR20070116217A | Republic of Korea | A | |
| CN101128483A | China | A | |
| HK1109409A1 | Hong Kong, China | A1 | |
| JP2008523841A | Japan | A | |
| US2008267971A1 | United States of America | A1 | |
| RU2007127842A | Russian Federation | A | |
| ZA200705695B | South Africa | B | |
| BRPI0519596A2 | Brazil | A2 | |
| NZ556029A | New Zealand | A | |
| RU2394839C2 | Russian Federation | C2 | |
| EP2284194A1 | European Patent Office (EPO) | A1 | |
| KR101017301B1 | Republic of Korea | B1 | |
| AU2005319382B2 | Australia | B2 | |
| US7973140B2 | United States of America | B2 | |
| EP1838733B1 | European Patent Office (EPO) | B1 | |
| AT521638TThis record | Austria | T | |
| ATE521638T1 | Austria | T1 | |
| DK1838733T3 | Denmark | T3 | |
| PT1838733E | Portugal | E | |
| ES2371083T3 | Spain | T3 | |
| SI1838733T1 | Slovenia | T1 | |
| HRP20110859T1 | Croatia | T1 | |
| JP4884395B2 | Japan | B2 | |
| PL1838733T3 | Poland | T3 | |
| US2012052073A1 | United States of America | A1 | |
| JP2012050455A | Japan | A | |
| RS52036B | Serbia | B | |
| CA2595610C | Canada | C | |
| US2013171160A1 | United States of America | A1 | |
| US8834880B2 | United States of America | B2 | |
| JP5642042B2 | Japan | B2 | |
| US2015125455A1 | United States of America | A1 | |
| CN101128483B | China | B | |
| CN105085678A | China | A | |
| CY1112909T1 | Cyprus | T1 | |
| HK1217713A1 | Hong Kong, China | A1 | |
| US10066011B2 | United States of America | B2 | |
| CN105085678B | China | B | |
| EP3699191A1 | European Patent Office (EPO) | A1 | |
| BRPI0519596B1 | Brazil | B1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5854387
Titles2
- German
- GEGEN ANGIOPOIETIN-2 GERICHTETE ANTIKÖRPER UND ANWENDUNGEN DAVON
- English
- ANGIOPOIETIN-2 ANTIBODIES AND APPLICATIONS THEREOF
Classification
- CPC, 19
- C07K16/22
- A61K2039/505
- A61K39/39558
- A61P1/00
- A61P1/16
- C07K14/515
- A61P1/18
- C07K2317/21
- A61P5/00
- C07K2317/56
- A61P9/00
- C07K2317/76
- A61P11/00
- C07K2317/92
- A61P13/00
- A61P13/12
- A61P17/00
- A61P35/00
- A61P43/00
- IPC, 4
- C07K16 22
- C07K16 28
- C12N15 13
- C12N15 85